Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Sex Difference in Relative Survival Following PCI

Published:

02 October 2024

Citation:

European Cardiology Review 2024;19:e18.

TAVR is Ready for Most Low-risk Patients

Published:

13 September 2024

Citation:

Cardiac Failure Review 2024;10:e11.

Decision-making in the Cardiac ICU

Published:

04 September 2024

Citation:

US Cardiology Review 2024;18:e13.

Stanford TAAD: Epidemiology and Surgical Outcomes

Published:

16 August 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e33.